Cargando…
Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway
AIM: The objective of this study is to determine if exuberant sympathetic nerve activity is involved in muscle satellite cell differentiation and myoblast fusion. METHODS AND RESULTS: By using immunoassaying and western blot analyses, we found that β1 and β2-adrenergic receptors (AdR) were expressed...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394105/ https://www.ncbi.nlm.nih.gov/pubmed/30819239 http://dx.doi.org/10.1186/s13287-019-1160-x |
_version_ | 1783398827289477120 |
---|---|
author | Chen, Shao-juan Yue, Jing Zhang, Jing-Xuan Jiang, Miao Hu, Tu-qiang Leng, Wei-dong Xiang, Li Li, Xin-yuan Zhang, Lei Zheng, Fei Yuan, Ye Guo, Lin-yun Pan, Ya-mu Yan, Yu-wen Wang, Jia-ning Chen, Shi-You Tang, Jun-ming |
author_facet | Chen, Shao-juan Yue, Jing Zhang, Jing-Xuan Jiang, Miao Hu, Tu-qiang Leng, Wei-dong Xiang, Li Li, Xin-yuan Zhang, Lei Zheng, Fei Yuan, Ye Guo, Lin-yun Pan, Ya-mu Yan, Yu-wen Wang, Jia-ning Chen, Shi-You Tang, Jun-ming |
author_sort | Chen, Shao-juan |
collection | PubMed |
description | AIM: The objective of this study is to determine if exuberant sympathetic nerve activity is involved in muscle satellite cell differentiation and myoblast fusion. METHODS AND RESULTS: By using immunoassaying and western blot analyses, we found that β1 and β2-adrenergic receptors (AdR) were expressed in C2C12 cells. The differentiated satellite cells exhibited an increased expression of β2-AdR, as compared with the proliferating cells. Continuous exposure of isoprenaline (ISO), a β-AdR agonist, delayed C2C12 cell differentiation, and myoblast fusion in time- and dose-dependent manner. ISO also increased short myotube numbers while decreasing long myotube numbers, consistent with the greater reduction in MyHC1, MyHC2a, and MyHC2x expression. Moreover, continuous exposure of ISO gradually decreased the ratio of PKA RI/RII, and PKA RI activator efficiently reversed the ISO effect on C2C12 cell differentiation and myoblast fusion while PKA inhibitor H-89 deteriorated the effects. Continuous single-dose ISO increased β1-AdR expression in C2C12 cells. More importantly, the cells showed enhanced phospho-ERK1/2 levels, resulting in increasing phospho-β2-AdR levels while decreasing β2-AdR levels, and the specific effects could be abolished by ERK1/2 inhibitor. Furthermore, continuous exposure of ISO induced FOXO1 nuclear translocation and increased the levels of FOXO1 in nuclear extracts while reducing pAKT, p-p38MAPK, and pFOXO1 levels. Conversely, blockade of ERK1/2 signaling partially abrogated ISO effects on AKT, p38MAPK, and FOXO1signaling, which partially restored C2C12 cell differentiation and myoblast fusion, leading to an increase in the numbers of medium myotube along with the increased expression of MyHC1 and MyHC2a. CONCLUSION: Continuous exposure of ISO impedes satellite cell differentiation and myoblast fusion, at least in part, through PKA-ERK1/2-FOXO1 signaling pathways, which were associated with the reduced β2-AdR and increased β1-AdR levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-019-1160-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6394105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63941052019-03-11 Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway Chen, Shao-juan Yue, Jing Zhang, Jing-Xuan Jiang, Miao Hu, Tu-qiang Leng, Wei-dong Xiang, Li Li, Xin-yuan Zhang, Lei Zheng, Fei Yuan, Ye Guo, Lin-yun Pan, Ya-mu Yan, Yu-wen Wang, Jia-ning Chen, Shi-You Tang, Jun-ming Stem Cell Res Ther Research AIM: The objective of this study is to determine if exuberant sympathetic nerve activity is involved in muscle satellite cell differentiation and myoblast fusion. METHODS AND RESULTS: By using immunoassaying and western blot analyses, we found that β1 and β2-adrenergic receptors (AdR) were expressed in C2C12 cells. The differentiated satellite cells exhibited an increased expression of β2-AdR, as compared with the proliferating cells. Continuous exposure of isoprenaline (ISO), a β-AdR agonist, delayed C2C12 cell differentiation, and myoblast fusion in time- and dose-dependent manner. ISO also increased short myotube numbers while decreasing long myotube numbers, consistent with the greater reduction in MyHC1, MyHC2a, and MyHC2x expression. Moreover, continuous exposure of ISO gradually decreased the ratio of PKA RI/RII, and PKA RI activator efficiently reversed the ISO effect on C2C12 cell differentiation and myoblast fusion while PKA inhibitor H-89 deteriorated the effects. Continuous single-dose ISO increased β1-AdR expression in C2C12 cells. More importantly, the cells showed enhanced phospho-ERK1/2 levels, resulting in increasing phospho-β2-AdR levels while decreasing β2-AdR levels, and the specific effects could be abolished by ERK1/2 inhibitor. Furthermore, continuous exposure of ISO induced FOXO1 nuclear translocation and increased the levels of FOXO1 in nuclear extracts while reducing pAKT, p-p38MAPK, and pFOXO1 levels. Conversely, blockade of ERK1/2 signaling partially abrogated ISO effects on AKT, p38MAPK, and FOXO1signaling, which partially restored C2C12 cell differentiation and myoblast fusion, leading to an increase in the numbers of medium myotube along with the increased expression of MyHC1 and MyHC2a. CONCLUSION: Continuous exposure of ISO impedes satellite cell differentiation and myoblast fusion, at least in part, through PKA-ERK1/2-FOXO1 signaling pathways, which were associated with the reduced β2-AdR and increased β1-AdR levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13287-019-1160-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-28 /pmc/articles/PMC6394105/ /pubmed/30819239 http://dx.doi.org/10.1186/s13287-019-1160-x Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chen, Shao-juan Yue, Jing Zhang, Jing-Xuan Jiang, Miao Hu, Tu-qiang Leng, Wei-dong Xiang, Li Li, Xin-yuan Zhang, Lei Zheng, Fei Yuan, Ye Guo, Lin-yun Pan, Ya-mu Yan, Yu-wen Wang, Jia-ning Chen, Shi-You Tang, Jun-ming Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title | Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title_full | Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title_fullStr | Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title_full_unstemmed | Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title_short | Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway |
title_sort | continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through pka/erk1/2-foxo1 signaling pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394105/ https://www.ncbi.nlm.nih.gov/pubmed/30819239 http://dx.doi.org/10.1186/s13287-019-1160-x |
work_keys_str_mv | AT chenshaojuan continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT yuejing continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT zhangjingxuan continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT jiangmiao continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT hutuqiang continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT lengweidong continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT xiangli continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT lixinyuan continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT zhanglei continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT zhengfei continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT yuanye continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT guolinyun continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT panyamu continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT yanyuwen continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT wangjianing continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT chenshiyou continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway AT tangjunming continuousexposureofisoprenalineinhibitsmyoblastdifferentiationandfusionthroughpkaerk12foxo1signalingpathway |